Ribonaut Therapeutics
Jupiter, US · Founded 2022 · Delaware corporation
Founders & leadership
ZC
Zachary CollinsNamed on SEC filing
ST
Steven TregayNamed on SEC filing
MD
Matthew DisneyNamed on SEC filing
LL
Lusong LuoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.9M disclosed across 1 round · 2022
▶$6.9MraisedJan 2023 · 6 investors · BiotechnologyRule 506(b)
▶$6.9MraisedJan 2023 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zachary CollinsExecutive Officer
- Steven TregayDirector
- Matthew DisneyExecutive Officer, Director
- Lusong LuoDirector
- Jessica Childs-DisneyPromoter
- Offering amount
- $26M
- Amount sold
- $6.9M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ribonaut Therapeutics raised?
- Ribonaut Therapeutics has disclosed $6.9M raised across 1 round.
- Where is Ribonaut Therapeutics headquartered?
- Ribonaut Therapeutics is headquartered in Jupiter, US.